Successful treatment of acne vulgaris using a new method: Results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel

Archives of Dermatology

Volumn 138, Issue 4, 2002, Pages 481-489

  Bershad, Susan ^a   Singer, Giselle Kranjac ^a   Parente, Janice E ^b   Tan, Mei Heng ^a   Sherer, Daniel W ^a   Persaud, Andrea N ^a   Lebwohl, Mark ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Integrated Research Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG VEHICLE; TAZAROTENE;

ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN IRRITATION;

ACNE VULGARIS; ADOLESCENT; ADULT; CHILD; FEMALE; GELS; HUMANS; MALE; NICOTINIC ACIDS; REMISSION INDUCTION; RETINOIDS; TIME FACTORS;

EID: 0036216569     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Topical vitamin A acid in acne vulgaris
2. Tazarotene gel, a new retinoid for topical therapy of psoriasis: Vehicle-controlled study of safety, efficacy, and duration of therapeutic effect
3. Preliminary observations on the use of topical tazarotene to treat basal-cell carcinoma
4. Photodamage pilot study: A double-blind, vehicle-controlled study to assess the efficacy and safety of tazarotene 0.1% gel
5. Effect of topical tazarotene in the treatment of congenital ichthyoses
6. A human retinoic acid receptor which belongs to the family of nuclear receptors
7. Identification of a receptor for the morphogen retinoic acid
8. Identification of a second human retinoic acid receptor
9. A third human retinoic acid receptor, hRAR-gamma
10. Tazarotene: The first receptor-selective topical retinoid for the treatment of psoriasis
11. Pharmacodynamics and pharmacokinetics of topical adapalene
12. Separation of transactivation and AP1 antagonism functions of retinoic acid receptor alpha
13. Retinoic acid receptor gene expression in human skin
14. Retinoic acid receptor gamma mediates topical retinoid efficacy and irritation in animal models
15. Response of psoriasis to a new topical retinoid, AGN 190168
16. Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive gene in skin
17. Negative regulation of two hyperproliferative keratinocyte differentiation markers by an RAR-selective retinoid: Insight into the mechanism of retinoid action in psoriasis
18. Topical treatment of acne vulgaris: Retinoids and cutaneous irritation
19. Developments in topical retinoid therapy for acne
20. Tazarotene gel is safe and effective in the treatment of acne vulgaris: A multicenter, double-blind, vehicle-controlled study
21. Efficacy and tolerability of once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.025% gel in the treatment of facial acne vulgaris: A randomized trial
22. Comparison of treatment of acne vulgaris with alternate-day applications of tazarotene 0.1% gel and once-daily applications of adapalene gel: A randomized trial
23. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: A multicenter trial
24. Comparison of adapalene 0.1% solution nd tretinoin 0.025% gel in the topical treatment of acne vulgaris
25. In vivo correlation between stratum corneum reservoir function and percutaneous absorption
26. The measurement of the stratum corneum reservoir: A predictive method for in vivo percutaneous absorption studies: Influence of application time
27. In vivo percutaneous penetration of some organic compounds related to anatomic site in humans: Predictive assessment by the stripping method
28. Pharmacokinetics and safety review of tazarotene
29. Retinoic acid embryopathy
30. Identification and quantification of all-trans- and 13-cis-retinoic acid and 13-cis-4-oxoretinoic acid in human plasma
31. Clinical pharmacokinetics and drug metabolism of tazarotene: A novel topical treatment for acne and psoriasis
32. Percutaneous absorption of AGN 190168, a new synthetic retinoid, through human skin in vivo